世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Alzheimers, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others), By Distribution Channel (Direct Sales v/s Indirect Sales), By Region & Competition,  2020-2030F

Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Alzheimers, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others), By Distribution Channel (Direct Sales v/s Indirect Sales), By Region & Competition, 2020-2030F


Market Overview The Global Oral Clinical Nutrition Market was valued at USD 15.89 billion in 2024 and is projected to reach USD 22.14 billion by 2030, growing at a CAGR of 5.68% during the forecas... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
TechSci Research
テックサイリサーチ
2025年6月30日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
PDF:2営業日程度 180 英語

 

Summary

Market Overview
The Global Oral Clinical Nutrition Market was valued at USD 15.89 billion in 2024 and is projected to reach USD 22.14 billion by 2030, growing at a CAGR of 5.68% during the forecast period. The market is witnessing strong growth due to increasing incidences of chronic diseases, greater emphasis on patient-focused care, and the rising prevalence of conditions like malnutrition, sarcopenia, and cachexia. These factors are driving demand for oral clinical nutrition products, which provide essential nutrients to patients who are unable to meet their dietary needs through regular food intake. The market comprises a broad range of products, such as nutritional supplements, enteral formulas, and medical foods, all formulated to support patient recovery and maintain health in clinical settings.
Key Market Drivers
Increasing Geriatric Population and Associated Malnutrition Risks
The global rise in the aging population is a key driver fueling demand for oral clinical nutrition products. As individuals age, they commonly experience reduced appetite, decreased digestive efficiency, and lower nutrient intake—factors that contribute to malnutrition, muscle loss, and weakened immunity. Oral clinical nutrition provides a solution by offering nutrient-dense formulations that are easy to consume and digest. According to the World Health Organization, by 2030, one in six people worldwide will be aged 60 years or older, and this number is expected to double by 2050. With aging comes a higher incidence of chronic diseases and nutritional deficiencies, positioning oral clinical nutrition as an essential component of elderly healthcare.
Key Market Challenges
High Cost and Limited Reimbursement in Developing Regions
The high cost of specialized oral clinical nutrition products remains a significant barrier, particularly in low- and middle-income countries. These products are often not included in government-funded health insurance schemes or essential medicine lists, placing the financial burden on patients and caregivers. Limited reimbursement policies restrict widespread adoption, particularly in underserved areas where healthcare access is already limited. The high production costs associated with disease-specific formulations further elevate retail prices, creating an affordability gap between developed and emerging markets. As a result, despite growing demand, market penetration remains constrained in economically disadvantaged regions.
Key Market Trends
Personalization in Clinical Nutrition Formulations
A growing trend in the oral clinical nutrition market is the development of personalized nutrition solutions. These are tailored to individual patient needs based on variables such as age, medical condition, genetic profile, and metabolic status. Advances in technologies like nutrigenomics and digital health tools are allowing clinicians to assess individual nutrient deficiencies and create targeted formulations that improve treatment outcomes. Personalized nutrition enhances patient compliance and efficacy, especially in complex cases such as cancer care, gastrointestinal recovery, and age-related deficiencies, thus establishing itself as a cornerstone of modern clinical nutrition strategies.
Key Market Players
• Abbott Laboratories, Inc.
• Pfizer, Inc.
• Bayer AG
• Nestle SA
• GlaxoSmithKline plc
• Baxter International Inc.
• Otsuka Holdings, Co. Ltd.
• Baxter International Inc.
• Victus, Inc.
• Danone SA (Nutricia)
Report Scope
In this report, the Global Oral Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Oral Clinical Nutrition Market, By Indication:
 o Alzheimer’s
 o Nutritional Deficiencies
 o Cancer Care
 o Chronic Kidney Disease
 o Dysphagia
 o Others
• Oral Clinical Nutrition Market, By Distribution Channel:
 o Direct Sales
 o Indirect Sales
• Oral Clinical Nutrition Market, By Region:
 o North America
  § United States
  § Mexico
  § Canada
 o Europe
  § France
  § Germany
  § United Kingdom
  § Italy
  § Spain
 o Asia-Pacific
  § China
  § India
  § South Korea
  § Japan
  § Australia
 o South America
  § Brazil
  § Argentina
  § Colombia
 o Middle East and Africa
  § South Africa
  § Saudi Arabia
  § UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Oral Clinical Nutrition Market.
Available Customizations
Global Oral Clinical Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).


ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Oral Clinical Nutrition Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Indication (Alzheimer’s, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others)
5.2.2. By Distribution Channel (Direct Sales v/s Indirect Sales)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Product Map
5.3.1. By Indication
5.3.2. By Distribution Channel
5.3.3. By Region
6. North America Oral Clinical Nutrition Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Indication
6.2.2. By Distribution Channel
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Oral Clinical Nutrition Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Indication
6.3.1.2.2. By Distribution Channel
6.3.2. Canada Oral Clinical Nutrition Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Indication
6.3.2.2.2. By Distribution Channel
6.3.3. Mexico Oral Clinical Nutrition Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Indication
6.3.3.2.2. By Distribution Channel
7. Europe Oral Clinical Nutrition Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Distribution Channel
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Oral Clinical Nutrition Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Indication
7.3.1.2.2. By Distribution Channel
7.3.2. Germany Oral Clinical Nutrition Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Indication
7.3.2.2.2. By Distribution Channel
7.3.3. United Kingdom Oral Clinical Nutrition Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Indication
7.3.3.2.2. By Distribution Channel
7.3.4. Italy Oral Clinical Nutrition Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Indication
7.3.4.2.2. By Distribution Channel
7.3.5. Spain Oral Clinical Nutrition Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Indication
7.3.5.2.2. By Distribution Channel
8. Asia-Pacific Oral Clinical Nutrition Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Distribution Channel
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Oral Clinical Nutrition Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Indication
8.3.1.2.2. By Distribution Channel
8.3.2. India Oral Clinical Nutrition Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Indication
8.3.2.2.2. By Distribution Channel
8.3.3. Japan Oral Clinical Nutrition Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Indication
8.3.3.2.2. By Distribution Channel
8.3.4. South Korea Oral Clinical Nutrition Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Indication
8.3.4.2.2. By Distribution Channel
8.3.5. Australia Oral Clinical Nutrition Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Indication
8.3.5.2.2. By Distribution Channel
9. South America Oral Clinical Nutrition Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Distribution Channel
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Oral Clinical Nutrition Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Indication
9.3.1.2.2. By Distribution Channel
9.3.2. Argentina Oral Clinical Nutrition Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Indication
9.3.2.2.2. By Distribution Channel
9.3.3. Colombia Oral Clinical Nutrition Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Indication
9.3.3.2.2. By Distribution Channel
10. Middle East and Africa Oral Clinical Nutrition Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Distribution Channel
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Oral Clinical Nutrition Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Indication
10.3.1.2.2. By Distribution Channel
10.3.2. Saudi Arabia Oral Clinical Nutrition Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Indication
10.3.2.2.2. By Distribution Channel
10.3.3. UAE Oral Clinical Nutrition Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Indication
10.3.3.2.2. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Oral Clinical Nutrition Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Abbott Laboratories, Inc.
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Pfizer, Inc.
15.3. Bayer AG
15.4. Nestle SA
15.5. GlaxoSmithKline plc.
15.6. Baxter International Inc.
15.7. Otsuka Holdings, Co. Ltd.
15.8. Baxter International Inc.
15.9. Victus, Inc.
15.10. Danone SA(Nutricia)
16. Strategic Recommendations
17. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社のヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD(nutrition)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/07/14 10:26

148.02 円

173.35 円

202.48 円

ページTOPに戻る